How Nerve-Driven Inflammation Causes Spinal Disc Degeneration
Neuropeptides substance P and CGRP released by nerve fibers growing into degenerating spinal discs drive neurogenic inflammation that accelerates disc breakdown.
Quick Facts
What This Study Found
Neurogenic inflammation driven by substance P and CGRP from ingrowing nociceptive nerve fibers plays a crucial role in intervertebral disc degeneration, with non-neuronal cells also contributing.
Key Numbers
Reviews substance P and CGRP release from nociceptive nerve fibers. Non-neuronal cells (disc cells, immune cells) express functional neuropeptide receptors. TRP channels contribute to neurogenic inflammation.
How They Did This
Review article synthesizing evidence on neurogenic inflammation mechanisms in intervertebral disc degeneration.
Why This Research Matters
Back pain from disc degeneration is one of the leading causes of disability worldwide. Understanding the neurogenic inflammation cycle could lead to targeted treatments that break the cycle and slow disc breakdown.
The Bigger Picture
The same neuropeptides (substance P, CGRP) implicated in migraine are now shown to drive spinal disc degeneration, suggesting anti-neuropeptide therapies could have applications in back pain.
What This Study Doesn't Tell Us
Review of existing literature — no new experimental data. The relative contribution of neurogenic versus other forms of inflammation in disc degeneration is still debated.
Questions This Raises
- ?Could anti-CGRP or anti-substance P therapies slow disc degeneration?
- ?What triggers the initial nerve ingrowth into degenerating discs?
Trust & Context
- Key Stat:
- Substance P + CGRP drive disc breakdown Neuropeptides released by nerve fibers growing into degenerating spinal discs create a vicious inflammatory cycle that accelerates degeneration
- Evidence Grade:
- Narrative review synthesizing preclinical and clinical evidence. Provides a comprehensive mechanistic framework but specific therapeutic implications remain to be tested.
- Study Age:
- Published in 2025, incorporating recent findings on non-neuronal cell contributions to neurogenic inflammation in discs.
- Original Title:
- Role of neurogenic inflammation in intervertebral disc degeneration.
- Published In:
- World journal of orthopedics, 16(1), 102120 (2025)
- Authors:
- Peng, Bao-Gan, Li, Yong-Chao, Yang, Liang
- Database ID:
- RPEP-13009
Evidence Hierarchy
Summarizes existing research without a strict systematic method.
What do these levels mean? →Frequently Asked Questions
What is neurogenic inflammation in the spine?
Neurogenic inflammation occurs when nerve fibers release inflammatory neuropeptides (substance P and CGRP) directly into tissue. In degenerating spinal discs, new nerve fibers grow inward and release these peptides, causing inflammation that further damages the disc.
Could migraine drugs help with back pain?
Theoretically, since the same neuropeptides (CGRP, substance P) are involved in both migraine and disc degeneration. However, this has not been tested, and delivering these drugs to spinal discs presents different challenges than treating headache.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-13009APA
Peng, Bao-Gan; Li, Yong-Chao; Yang, Liang. (2025). Role of neurogenic inflammation in intervertebral disc degeneration.. World journal of orthopedics, 16(1), 102120. https://doi.org/10.5312/wjo.v16.i1.102120
MLA
Peng, Bao-Gan, et al. "Role of neurogenic inflammation in intervertebral disc degeneration.." World journal of orthopedics, 2025. https://doi.org/10.5312/wjo.v16.i1.102120
RethinkPeptides
RethinkPeptides Research Database. "Role of neurogenic inflammation in intervertebral disc degen..." RPEP-13009. Retrieved from https://rethinkpeptides.com/research/peng-2025-role-of-neurogenic-inflammation
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.